Evidence map›Paper›PMID 28868416›Full record

ReviewGE Portuguese journal of gastroenterology

Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?

José Pedro Portela-Cidade, Marta Borges-Canha, Adelino Ferreira Leite-Moreira, Pedro Pimentel-Nunes

Open access · diamondAbstract readReview
In one paragraph

Review in GE Portuguese journal of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Maternal Supplementation withDiseases (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Genes · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

José Pedro Portela-CidadePhysiology and Cardiothoracic Surgery Department, Cardiovascular Research & Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Marta Borges-CanhaPhysiology and Cardiothoracic Surgery Department, Cardiovascular Research & Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Adelino Ferreira Leite-MoreiraPhysiology and Cardiothoracic Surgery Department, Cardiovascular Research & Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Pedro Pimentel-NunesPhysiology and Cardiothoracic Surgery Department, Cardiovascular Research & Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Universidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMetabolic syndrome is an emerging problem in developed countries and presents itself as a potential threat worldwide. The role of diabetes, dyslipidaemia and hepatic steatosis as pivotal components of the metabolic syndrome is well known. However, their common persistent chronic inflammation and its potential cause still elude. This systematic review aims to present evidence of the mechanisms that link the intestinal microbioma, innate immunity and metabolic syndrome.

methodsA comprehensive research was made using PubMed database and 35 articles were selected.

resultsWe found that metabolic syndrome is associated to increased levels of innate immunity receptors, namely, Toll-like receptors, both in intestine and systemically and its polymorphisms may change the risk of metabolic syndrome development. Microbioma dysbiosis is also present in metabolic syndrome, with lower prevalence of Bacteroidetes and increased prevalence of Firmicutes populations. The data suggest that the link between intestinal microbiota and Toll-like receptors can negatively endanger the metabolic homeostasis.

conclusionCurrent evidence suggests that innate immunity and intestinal microbiota may be the hidden link in the metabolic syndrome development mechanisms. In the near future, this can be the key in the development of new prophylactic and therapeutic strategies to treat metabolic syndrome patients.

Indexed as

Immunity, InnateIntestinal MucosaMetabolic Syndrome XMicrobiotaToll-Like Receptors

Identifiers

PMID28868416
PMCPMC5580162
OpenAlexW1127470650

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.